Indian Markets Extend Losing Streak as Trump's Pharma Tariffs Spook Investors; Sensex Down 320 Points

Indian benchmark indices continued their bearish trend for the fifth consecutive session on Friday, September 26, 2025, as investors reacted negatively to US President Donald Trump's announcement of punitive tariffs on pharmaceutical imports. The BSE Sensex dropped 320 points to trade at 80,872 levels, while the NSE Nifty50 fell below the crucial 24,800 mark, declining by 74 points to 24,816. Sectoral Performance Hit by Global Headwinds : The market selloff was broad-based with most sectoral indices trading in negative territory. The Nifty Pharma index emerged as the worst performer, plummeting over 2% following Trump's announcement of a 100% tariff on branded and patented pharmaceutical products effective October 1, 2025. The IT sector also faced significant pressure, declining 1-2%, weighed down by weak growth outlook from global consulting major Accenture. Banking stocks extended their losing streak for the third consecutive day, with the Nifty Bank index falling 0.6%. Major private sector banks including ICICI Bank, Kotak Mahindra Bank, and HDFC Bank traded with cuts of 0.3-1%. The PSU Bank index also declined over 1%, with UCO Bank, Punjab & Sind Bank, and Bank of Maharashtra among the top losers. Major Stock Movements : Among individual stocks, pharmaceutical giants bore the brunt of selling pressure. Sun Pharma, India's largest drug manufacturer, declined over 4%, while other major players including Biocon, Cipla, Dr. Reddy's Labs, Lupin, and Aurobindo Pharma fell between 1-6%. IT bellwethers Infosys, HCL Technologies, and Tech Mahindra also faced significant selling pressure. On the positive side, infrastructure and metal stocks provided some cushion to the broader market decline. Larsen & Toubro, Hero MotoCorp, JSW Steel, and Tata Steel emerged among the top gainers on the Nifty. Notably, over 6.17 million shares of Titan Company were traded in block deals, while ICICI Bank witnessed block trades of 1.02 million shares, indicating institutional activity. IPO Market Activity : The primary market saw mixed responses with several IPOs making their debut. GK Energy shares listed with a decent 12% premium on NSE, while Saatvik Green Energy made a tepid debut, listing flat at its IPO price. However, Siddhi Cotspin disappointed investors with a weak 20% discount listing on NSE Emerge. Among ongoing issues, Anand Rathi Share and Stock Brokers IPO was subscribed 20.6 times, while TruAlt Bioenergy received modest 44% subscription on its first day. Corporate Developments : Several companies announced significant developments during the session. RITES bagged an international order worth $18 million from South Africa for locomotive supply and commissioning. Amber Enterprises India secured Rs 550 crore investment from multiple investors for its subsidiary IL JIN Electronics. Ceigall India's joint venture won a road construction project worth Rs 509.2 crore from Greater Mohali Area Development Authority. Supreme Petrochem commissioned its ABS project at Maharashtra with 70,000 TPA capacity. Market Outlook and Analysis : Market experts attribute the continued weakness to multiple headwinds including sustained Foreign Institutional Investor (FII) selling and uncertainty over US trade policies. VK Vijayakumar of Geojit Investments noted that Trump's shift from country-specific to product-specific tariffs indicates continued weaponization of trade policy, which may persist until US inflation spikes. Technical analysts warn that the Nifty's fall below the crucial support level of 25,050 and the 21-day EMA confirms increasing bearish sentiment. The immediate support is placed at 24,800, with any decisive breach potentially triggering deeper corrections. Despite the near-term challenges, analysts suggest investors can utilize market dips to accumulate quality stocks, particularly those driven by domestic consumption, as the fundamentals of the Indian economy remain intact. The broader market indices also reflected the negative sentiment, with BSE MidCap declining 0.6% and SmallCap index shedding 0.8%, extending their losing streak to multiple days. - MarketForesee Research Desk ----------------------------------------------------------------------------------------------------------------------------- Indian stock market | Sensex today | Nifty 50 | Trump tariffs pharma | pharmaceutical stocks | IT stocks decline | market crash | BSE NSE | stock market news | Indian shares fall | banking stocks | sectoral performance | IPO listings | corporate earnings | FII selling | market outlook September 2025